Tempest Therapeutics, Inc.TPSTNASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank46
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-7.24
↑ 43% vs avg
Percentile
P46
Within normal range
Streak
1 yr
Consecutive growthElevated
Average
-12.65
Historical baseline
PeriodValueYoY Change
2024-7.24+75.8%
2023-29.90-7942.8%
2022-0.37+47.3%
2021-0.71-3.6%
2020-0.68+97.5%
2019-26.95-358.3%
2018-5.88-10302.8%
2017-0.06+99.3%
2016-7.77+83.5%
2015-46.96-